Navigation Links
Atherotech Recruits Top Experts in Fight Against Heart Disease
Date:3/15/2010

BIRMINGHAM, Ala., March 15 /PRNewswire/ -- With heart disease continuing to be the No. 1 cause of death in the U.S., Atherotech Inc. has recruited eight top cardiovascular experts to its medical advisory board to help guide development of a new preventive program. The company is expanding its disease management services with the goal of helping physicians reduce death and disability from heart disease.

These experts will advise Atherotech, maker of the patented VAP Cholesterol Test, in the expansion of its disease management program. The physicians bring expertise in current trends in cardiovascular disease identification, risk assessment and management, and research and outcome studies.

The new advisory board members are distinguished medical doctors Eliot A. Brinton, Michael H. Davidson, Prakash C. Deedwania, Gary H. Gibbons, Peter H. Jones, Richard B. Lanman, Charles A. Reasner II, and Peter P. Toth. Among them, these medical experts hold 16 fellowships or board certifications from various respected medical societies. To review individual detailed biographies, please visit www.atherotech.com/mad.

Atherotech announced the board appointments during the American College of Cardiology 59th Annual Scientific Session Exposition in Atlanta. "Collectively the members of this board have more than 150 years of clinical research, nearly 1,000 publications and over 200 years of clinical patient care," said Atherotech Chief Medical Officer Michael E. Cobble. "They will help intensify our focus on highlighting major and residual lipid risks in patients at risk or who already have cardiovascular disease."

Each board member contributes specific expertise. "Our research efforts are focused on discovering who is truly at risk for cardiovascular disease and how we can better manage this risk," said Dr. Davidson. "The past focus only on LDL/HDL/triglycerides misses nearly half of patients at risk."

Dr. Davidson is Executive Medical Director of Radiant Research in Chicago, which operates 21 centers around the nation that focus on lipid research. "By serving on the medical advisory board, I hope to increase awareness of the benefits of advanced lipid testing and its utility to physicians and patients," he said.

Dr. Toth, a family practitioner at Sterling Rock Falls Clinic in Sterling, Ill., began using the advanced lipid profile for its powerful predictive factors.

"I started using Atherotech's VAP Test in my practice because it is highly cost effective and reports 22 lipid and cardiovascular risk parameters that help me better assess and treat patients. When half of people who experience heart attacks have no idea they are even at risk, we need more information to manage these patients," said Dr. Toth, who is Chief of Medicine at CGH Medical Center in Sterling and Clinical Associate Professor at the University of Illinois School of Medicine. "I am pleased to serve on the medical advisory board of a company whose services help me take the care of my patients to a higher level."

An associate professor at the Center for Cardiovascular Disease Prevention at the Baylor College of Medicine in Houston, Dr. Jones performs clinical trials of new lipid-modifying drugs. He is site principal investigator of the AIM HIGH trial, a NIH-funded 4-year outcomes study.

"Advanced lipid testing is essential to my work as a clinical investigator to improve risk assessment and to potentially further reduce patients' risk," Dr. Jones said. "I'm also interested in obesity research, particularly in the effects of weight reduction on plasma markers of inflammation and insulin sensitivity. Atherotech is committed to expanding services into disease management, and I am looking forward to being a part of their efforts."

Atherotech provides physicians and cardiology practices with a single source for the VAP Cholesterol Test and more than a dozen cardiovascular and metabolic tests. Cardiometabolic testing available through Atherotech includes C-reactive protein (hs-CRP), Lp-PLA2, apoE genotype, NT-proBNP, Cystatin C, T3 and T4 when TSH is abnormal, plus gamma-glutamyl transferase (GGT), a recognized cardiovascular risk biomarker.

The VAP Test includes Lp(a) at no additional cost and identifies markers of metabolic syndrome, which is frequently associated with early diabetes. It is the only single cholesterol test that routinely reports apoAI, apoB and the apoB/apoAI ratio.

For more information on the VAP Test, visit www.thevaptest.com or call 877.901.8510.

About Atherotech Inc.

Atherotech is a CLIA-certified clinical reference laboratory and cardiodiagnostic company focusing on cardiometabolic tests, including the company's patented VAP Cholesterol Test, which reports the cholesterol content of all lipids, components and subclasses. The VAP Test is the first cholesterol profile to comply with updated National Cholesterol Education Program ATP III recommendations for direct LDL measurement, which is accurate with non-fasting samples. It is the only advanced lipid profile that routinely reports all three lipoprotein parameters considered necessary by the American Diabetes Association and American College of Cardiology expert consensus guidelines. The VAP Test is available through national and regional diagnostic laboratories and is reimbursed by many of the largest private insurers as well as Medicare. For more information, visit www.thevaptest.com.

SOURCE Atherotech Inc.

Back to top

RELATED LINKS
http://www.atherotech.com

'/>"/>

SOURCE Atherotech Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Atherotech to Exhibit VAP(R) Cholesterol Test at American Heart Association Scientific Sessions 2009
2. International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia
3. Malaria Experts Call on Federal Government to Increase Support for Research and Development
4. Panel of Osteoarthritis Experts Develops Optimal Profile of Exogenous Hyaluronic Acid
5. Medicinal Use of Marijuana: Past, Present and Future...A Fresh Look by Experts in the Field
6. PRA International Experts Present a Session at the 8th Annual Partnerships in Clinical Trials 2009
7. New Incision-Less Procedure for REFLUX - Experts Consider it to Be Gold Standard for REFLUX
8. Risk Evaluation and Mitigation Strategy Experts Interpret New FDA REMS Guidance
9. Kendle Experts to Share Insights at the Regulatory Affairs Professionals Society Annual Conference and Exhibition
10. H3N2 Influenza Unlikely to Spread Between Humans, K-State Infectious Disease and Diagnostics Experts Say; Swine Exhibits at Fairs are Safe With Proper Hygiene
11. Leading Experts Endorse Biohearts Muscle Stem Cell MyoCell Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... 2, 2017 The Rebound mobile app is poised ... reverse the tide of prescription drug addiction. The app empowers ... intake and stepping down their dosage in a safe, controlled ... December 2017; the first 100,000 people to sign up will ... http://www.rebound-solution.com/ ...
(Date:9/27/2017)... Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... its MyDario product is expected to appear on The Dr. Oz Show ... Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked off ... The segment features ...
(Date:9/22/2017)... 2017  As the latest Obamacare repeal effort moves ... (R-LA) and Lindsey Graham (R-SC) medical ... device industry is in an odd place.  The industry ... excise tax on medical device sales passed along with ... patients, increased visits and hospital customers with the funding ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... most popular and least understood books in the Holy Scriptures, Revelation. The Book of ... baffled scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance ... management, will showcase a range of technology and learning solutions at the 68th ... and Expo to be held October 14–18, 2017 at the Mandalay Bay Resort ...
(Date:10/12/2017)... , ... October 12, 2017 , ... The American College ... to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in ... , In honor of Morris F. Collen, a pioneer in the field of medical ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts ... Washington, D.C., for the 49th Congress of the International Society of Paediatric Oncology ... of the Center for Cancer and Blood Disorders at Children’s National, and ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vohra Chief Medical Officer ... physician colleagues, skilled nursing facility medical directors and other clinicians at various events ... Care." , "At many of these conferences we get to educate other physicians, ...
Breaking Medicine News(10 mins):